Jecho Biopharmaceuticals Co., Ltd.
Clinical trials sponsored by Jecho Biopharmaceuticals Co., Ltd., explained in plain language.
-
New injection aims to boost immune systems in HIV patients
Disease control Not yet recruitingThis early-stage study is testing an experimental injection called JL18008 in people living with HIV. It's designed for patients whose immune systems remain weak despite taking effective antiviral medications. The research will first check if the injection is safe, then see if it…
Phase: PHASE1 • Sponsor: Jecho Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New bladder cancer drug enters first human trials
Disease control Not yet recruitingThis early-stage study aims to test the safety and determine the right dose of an experimental drug called JL19001 injection for people with high-risk non-muscle invasive bladder cancer. The drug will be tested alone and in combination with the standard BCG treatment. Researchers…
Phase: PHASE1 • Sponsor: Jecho Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC